Olaparib reverses prostate cancer resistance to Rapamycin by promoting macrophage polarization towards the M1 phenotype
Kai Ye(Nanyang Technological University), Yuqiang Mi(Tianjin Infectious Diseases Hospital), Yu Zhu(The University of Queensland), Jian Xu(University of California, Los Angeles), Kunyan Qiao(Tianjin Infectious Diseases Hospital), Yu Cao(Kunming Medical University), Qinghai Dai(Tianjin Infectious Diseases Hospital), Ping Li(Tianjin University of Traditional Chinese Medicine), Yue Hu(Tianjin Infectious Diseases Hospital), Rui Su(City of Hope), Gang Shi(Tianjin Anding Hospital), Lihua Yan(Tianjin People's Hospital), Zhixiao Huo(Tianjin Infectious Diseases Hospital), Wei Liu(Chinese Academy of Sciences), Liang Xu(Tianjin University of Traditional Chinese Medicine)
Cited by 2
Related Papers
Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses
|Cancer Research|2012|941
HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
|Gastric Cancer|2014|615
Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis
|Molecular Carcinogenesis|2010|558
Cationic Peptidopolysaccharides Show Excellent Broad‐Spectrum Antimicrobial Activities and High Selectivity
|Advanced Materials|2012|267
Drug resistance to targeted therapeutic strategies in non-small cell lung cancer
|Pharmacology & Therapeutics|2019|245